Here’s what researchers know and don’t know about COVID-19’s neurological manifestations. “If someone has weakness in their left arm, and they don’t use their…
The latest news about Biogen’s controversial Alzheimer’s drug popped into my email at 8:26 a.m. last Wednesday. Coincidentally it arrived just as I was…
New research raises concerns about access to guns for people with dementia, and caregivers search for expert guidance on how to address gun safety…
The National Center for Health Statistics attributes 266,000 deaths per year to Alzheimer’s and other forms of dementia. Upwards of 120,000 of those per…
Can a gene that naturally suppresses Alzheimer’s in brain cells pave the way to curing it? In 2012, excitement rippled through the scientific community…
Alzheimer’s clinical trials may take decades, but a new discovery could cut clinical trial time down to a matter of weeks. For nearly a century,…
Scientists at UCSF have discovered an exercise enzyme. Exercise is one of the most well-studied and most powerful ways of protecting the brain from…
In another step toward what could be the first treatment for early stage Alzheimer’s, Biogen and Eisai today said they have completed an application…
As research into Alzheimer’s disease progresses and awareness grows, one fact remains consistent: women are disproportionately affected by the disease. Several theories exist, but…
Alzheimer’s disease does discriminate when it comes to gender. Two thirds of all cases are women, and in the past it was believed that…
For many contemplating end-of-life planning and the later stages of dementia and other cognitive disorders, euthanasia and assisted suicide remain contentious issues. While the…
Almost 30 years ago, a small faction of Alzheimer’s researchers proposed the infectious theory of Alzheimer’s — the idea that viruses or bacteria may…
Millions of Americans live with Alzheimer’s and other forms of dementia — and millions more take care of them. By 2050, cases of Alzheimer’s…
More than 5.5 million people in the United States live with Alzheimer’s — one in every ten people over the age of 65. Knowing…
The newest possible model to test therapeutics and interventions for neurodegenerative diseases could be a 20-year-old baboon. Researches have recently discovered that, just like…